Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 10,861 | 21,807 | 11,790 | 11,175 | 10,460 |
| Gross Profit | 10,861 | 21,807 | 11,790 | 11,175 | 10,460 |
| Operating Expenses | 49,915 | 49,472 | 43,462 | 47,405 | 54,995 |
| Operating Income | -39,054 | -27,665 | -31,672 | -36,230 | -44,535 |
| Interest Expense | 7,942 | 9,769 | 6,047 | 5,394 | 4,974 |
| Other Income | 2,156 | 1,386 | 2,164 | -157 | -1,321 |
| Pre-tax Income | -44,840 | -36,048 | -35,555 | -41,781 | -50,830 |
| Income Tax | 64 | 31 | -33 | -188 | 52 |
| Net Income Continuous | -44,904 | -36,079 | -35,522 | -41,593 | -50,882 |
| Net Income | $-44,904 | $-36,079 | $-35,522 | $-41,593 | $-50,882 |
| EPS Basic Total Ops | -1.82 | -1.29 | -1.87 | -2.95 | -3.62 |
| EPS Basic Continuous Ops | -1.82 | -1.28 | -1.87 | -2.95 | -3.62 |
| EPS Diluted Total Ops | -1.82 | -1.29 | -1.87 | -2.95 | -3.62 |
| EPS Diluted Continuous Ops | -1.82 | -1.28 | -1.87 | -2.95 | -3.62 |
| EPS Diluted Before Non-Recurring Items | -1.82 | -1.78 | -1.85 | -2.78 | -3.30 |
| EBITDA(a) | $-40,566 | $-23,849 | $-32,909 | $-36,885 | $-45,433 |